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Abstract 29 
Under normal physiological conditions, the intestinal immunity remains largely 30 
hyporesponsive to the commensal microbiota, yet also retains the inherent ability to rapidly 31 
respond to pathogenic antigens. However, immunomodulatory activities of extracellular 32 
products from commensal bacteria have been little studied, with previous investigations 33 
generally utilising the live bacterium to study microbiota-epithelial interactions. In this study, 34 
we demonstrate that extracellular products of a commensal bacterium, Escherichia coli C25, 35 
elicit a moderate release of proinflammatory IL-8 and stimulate transcriptional up-regulation 36 
of Toll-like receptors (TLRs) in intestinal epithelial cell lines, HT29-19A and Caco-2. 37 
Additionally, we show that removal of outer membrane vesicles (OMVs) reduces the 38 
proinflammatory effect of secreted products from E. coli C25. Furthermore, we show that 39 
isolated OMVs have a dose-dependent proinflammatory effect on IECs. Interestingly, a 40 
relatively high concentration (40 µg/ml protein) of OMVs had no significant regulatory 41 
effects on TLR mRNA expression in both cell lines. Finally, we also demonstrate a that pre-42 
incubation with E. coli C25-derived OMVs subsequently inhibited the internalisation of the 43 
bacterium itself in both cell lines. Taken together, our results suggest that commensal-derived 44 
extracellular products, in particular OMVs, could significantly contribute to intestinal 45 
homeostasis. We also demonstrate a unique interaction between commensal-derived OMVs 46 
and host cells.   47 
 48 
  49 
Introduction 50 
The intestinal commensal microbiota, consisting of ~10
14
 bacteria [1], is considered one of 51 
the densest and most diverse microbial communities on the planet [2]; consequently, our 52 
knowledge of the highly dynamic role the microbiota plays in host immunity is still very 53 
basic. Nevertheless, advances in technology have allowed some compositional 54 
characterisation of the commensal microbiota via metagenomic analyses [1,3]. For example, 55 
in early neonatal life, E. coli are among the first bacteria to colonise the human intestine [4] 56 
and these early commensal pioneers offer a preliminary defence against enteropathogens, due 57 
to physical and nutritional competition [5]. An early example of a commensal bacterium is E. 58 
coli C25 which was originally isolated from the faeces of a healthy individual in the mid-59 
1950s [6] and was subsequently demonstrated to have antagonistic activities against the 60 
enteric pathogen, Shigella flexneri [7,8]. Also, C25 lacks the traditional virulence genes 61 
found in pathogenic strains of E. coli, such as extraintestinal pathogenic (ExPEC), 62 
enterohaemorrhagic (EHEC) and enteropathogenic (EPEC) [9,10]; moreover, it is a poor 63 
recipient of plasmid transfer [11], so is unlikely to acquire such genes from other bacteria. 64 
Nevertheless, studies utilising live C25 have demonstrated its ability to translocate through 65 
the intestinal epithelial barrier [10,12,13] and to initiate a proinflammatory response in 66 
intestinal epithelial cell lines [9,10,12,14]. Yet, the immunoregulatory ability of the 67 
extracellular products from C25 have only been briefly considered previously [15].  68 
Gram negative bacteria, and E. coli in particular, are well characterised in their 69 
production of outer membrane vesicles (OMVs) [16-20], which are small (50-250 nm 70 
diameter), spherical, bilayered membranous structures naturally secreted into the bacterium’s 71 
immediate surroundings [21]. OMVs have been isolated from a diverse range of 72 
environments, from liquid and solid lab cultures to river beds and waste water pipes [22], and 73 
even from the human body [23,24]. The composition, conformation and surface chemistry of 74 
OMVs is representative of the intact outer membrane (OM) of Gram-negative bacteria, with 75 
lipopolysaccharides (LPSs), outer membrane proteins (OMPs), phospholipids and 76 
periplasmic proteins all present [17,21]. Therefore, it is unsurprising that OMVs from 77 
pathogens, such as Pseudomonas aeruginosa, Helicobacter pylori and Vibrio cholera have 78 
been suggested to contribute to the pathology of chronic inflammatory diseases, as they 79 
exhibit the ability to elicit IL-8 from gastric [25], bronchial [26] and intestinal epithelial cells 80 
[27,28], respectively. However, more recent studies have focussed on OMVs derived from 81 
probiotic bacteria, such as E. coli Nissle 1917 [18,29] and commensal bacteria, such as 82 
Bacteroides fragilis [30], Bacteroides thetaiotaomicron [31] and E. coli strain ECOR12 [29]. 83 
Nevertheless, with the recent exception of Fábrega et al., who showed that the two strains of 84 
E. coli studied were able to stimulate cytokine release from explanted colonic tissue [29], the 85 
direct interactions of OMVs from non-pathogenic bacteria with the host intestinal epithelium 86 
have been little studied [32]. Therefore, the current study aimed to investigate the direct 87 
inflammatory potential of OMVs derived from E. coli C25 on the intestinal epithelial cell 88 
lines, HT29-19A and Caco-2.  89 
90 
Materials and Methods 91 
Cell culture 92 
HT29-19A and Caco-2 cell lines were kindly donated by Prof. G. Warhurst (Royal NHS 93 
Foundation Trust and University of Salford, UK). Both cell lines were cultured in a standard 94 
media of high glucose (4500mg/l) Dulbecco’s Modified Eagles Media (DMEM), 10 % foetal 95 
bovine serum (FBS), 4 mM glutamine and a mixture of 50 IU/ml penicillin and 50 µg/ml 96 
streptomycin (PenStrep). Additionally, HT29-19A cells were supplemented with 20 mM 97 
HEPES and Caco-2 cells had 0.1 mM MEM NEAA (non-essential amino acids) added. Both 98 
cell lines were seeded at a density of 0.5 x 10
5
 cells/cm
2
 and cultured to confluence (~7 days) 99 
in 35 mm x 10 mm cell culture dishes. After culturing the cells to confluence on tissue culture 100 
plastic over 7 days, both cell lines became semi-polarised; indeed, Caco-2 cells were 101 
observed to undergo dome formation, which is indicative of unidirectional water transport 102 
and polarisation. 103 
 104 
Bacterial products 105 
E. coli C25 was a kind gift from Prof. G. Warhurst and was cultured on tryptone soy agar 106 
(TSA) at 37 °C. DMEM, supplemented with 4 mM glutamine was inoculated with E. coli 107 
C25 and incubated overnight (~15 h), until the culture reached the stationary phase of growth 108 
(Supplementary Fig 1; ~1 x 10
9
 CFU/ml). Subsequent to incubation, the culture was 109 
centrifuged at 6000 x g for 10 min to pellet out the bacteria. The supernatant was removed, 110 
had its pH adjusted to 7.4 and was subsequently filtered using 0.45 μm syringe-driven filters 111 
(Millex
®
, Millipore UK Ltd.). The cell-free supernatant was diluted 1:10 in cell culture 112 
medium and used in cell challenge experiments.  113 
 10 ml aliquots of overnight E. coli C25 cultures in DMEM with 4 mM glutamine 114 
(containing ~1 x 10
9
 CFU/ml) were sonicated, using a Vibracell VCX 130 (Sonics and 115 
Materials Inc.) at 85 % amplitude for a 5 x 6 s pulse program. Cultures were sonicated on ice 116 
and with a 24 s cooling step between pulses, in order to minimise denaturation of bacterial 117 
products. Resultant solutions were filtered through a 0.45 µm syringe-driven filter, diluted 118 
1:10 in cell culture medium and subsequently used in cell challenge experiments. 119 
Flagellin isolated from Salmonella typhimurium strain 14028 was purchased from 120 
Enzo Life Sciences Ltd. 121 
 122 
Cytokine stimulation and analysis 123 
Cells were challenged with the bacterial stimuli for 24 h, at 37 °C, 5 % CO2 and constant 124 
humidity. Supernatants were collected and frozen at -80 °C until assayed for IL-8 by enzyme-125 
linked immunosorbant assay (ELISA) analysis (IL-8 Human Antibody Pairs, Invitrogen). 126 
ELISA analysis was carried out according to the manufacturer’s instructions.  127 
 128 
qPCR 129 
Epithelial cells were challenged with the bacterial stimuli for 24 h. The cells were 130 
subsequently lysed and the total RNA was extracted using the RNeasy
®
 Mini Kit and RNase-131 
free DNase Set (Qiagen). RNA was quantified spectrophotometrically using the absorbance 132 
at 260 nm (A260) x 44 μg/ml x dilution factor and the purity was measured using A260/A280. 133 
cDNA was synthesised from 2 μg of total RNA by the iScript™ cDNA Synthesis Kit (Bio-134 
Rad Laboratories Ltd.). cDNA synthesis was carried out to the manufacturer’s instructions.  135 
PCR primers (Table 1) were purchased from Eurofins MWG Operon. Universal 136 
ProbeLibrary probes and Lightcycler
®
 Taqman
®
 Master Mix were purchased from Roche 137 
Diagnostics Ltd. Amplification was carried out in 20 μl reaction volume containing 1.5 μl 138 
cDNA, 0.5 μl F-primer and R-primer (0.4 μM), 0.5 μl Universal probe, 4 μl 5x Mastermix 139 
and 13 μl DNase/RNase-free water. The following program was used: 95 °C for 10 min 140 
followed by 45 cycles of 95 °C for 10 s, 60 °C for 30 s and 72 °C for 1 s. Target gene 141 
expression was normalised to the housekeeping gene GAPDH, and the fold difference of 142 
expression from the control was calculating using the 2
-ΔΔCt
 method [33]. 143 
  144 
OMV isolation  145 
Outer membrane vesicle (OMV) isolation was achieved by a well-established method first 146 
described by Kadurugamuwa and Beveridge [34] and more recently modified by Vanaja et al. 147 
[35] and Fabrega et al. [29]. Briefly, 250 ml overnight (15 h) cultures of E. coli C25 in 148 
tryptone soy broth (TSB) were centrifuged at 6000 x g for 10 min to pellet out the bacteria. 149 
The supernatant was sequentially filtered through 0.80 and 0.45 μm pore size vacuum-driven 150 
bottle top filters. A sample of the filtrate was transferred to TSA plates and incubated at 37 151 
°C to ensure there was no contaminating bacteria were present. The filtrates were 152 
ultracentrifuged at 150,000 x g for 1.5 h, at 5 °C, to pellet out the OMVs. The supernatant 153 
was removed and the pellet was resuspended in 50 mM HEPES buffer (pH 6.8) and 154 
ultracentrifuged again for 30 min at 120,000 x g, 5 °C. The supernatant was again removed 155 
and the pellet was resuspended in 50 mM HEPES buffer (pH 6.8), filtered through a 0.45 μm 156 
syringe filter and stored at 4 °C. Approximately 400 μg OMVs by protein concentration were 157 
isolated from 250 ml culture supernatant, measured by the modified Lowry assay as per the 158 
manufacturer’s instructions (DC™ Protein Assay; Bio-Rad). Subsequently, OMVs were 159 
serially diluted (to give 4-100 μg/ml protein) in cell culture medium and utilised in cell 160 
challenge experiments. 161 
 162 
Outer membrane isolation 163 
E. coli C25 outer membrane (OM) was isolated using a slightly modified protocol from that 164 
previously described by Zhou et al. [36]. Briefly, 250 ml overnight (15 h) cultures of E. coli 165 
C25 grown in TSB were centrifuged at 10,000 x g for 10 min and the resultant pellet was 166 
washed twice in PBS. The bacterial pellet was then resuspended in 10ml PBS with 0.01 M 167 
EDTA, incubated at room temperature for 30 min and sonicated for 10 s at 85% amplitude. 168 
The mixture was then centrifuged again at 10,000 x g for 10 min at 4°C and the supernatant 169 
was collected, with the pellet being discarded. The supernatant was subsequently centrifuged at 170 
80,000 x g for 2 h at 4°C. The translucent yellow pellet was resuspended in sterile water and 171 
was centrifuged again at 80,000 x g for 2 h at 4°C. The final pellet was resuspended in sterile 172 
water and frozen at -80°C [36]. 173 
 174 
Transmission electron microscopy 175 
OMVs were isolated and resuspended at approximately 1 mg/ml protein content in 50 mM 176 
HEPES buffer (pH 6.8). Vesicles were placed on Carbon Films on 400 Copper Mesh Grids 177 
(Agar Scientific) for 1 min. Grids were then negatively stained with 1% aqueous uranyl acetate 178 
for 1 min and visualized on a LoJeol 1200EX TEM.  179 
 180 
SDS-PAGE 181 
Protein concentrations of isolated OMVs and OMs were measured using the modified Lowry 182 
assay as per the manufacturer’s instructions (DC™ Protein Assay; Bio-Rad), with BSA used 183 
as a protein standard (Sigma-Aldrich). 30 µg of samples were heated at 70°C for 10 minutes 184 
and subsequently resolved on a 4-12% NuPAGE Novex Bis-Tris precast protein gel 185 
(Invitrogen) in 1x MES buffer (50 mM MES, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA, pH 186 
7.0). The gel was then stained using the Pierce
™
 Silver Stain Kit (Thermo Scientific) to the 187 
manufacturer’s instructions and viewed using the InGenius gel viewing cabinet (Syngene) 188 
and GeneSnap software (Syngene). 189 
 190 
Bacterial internalisation assay 191 
The method for this assay was developed from the technique described by Macutkiewicz et 192 
al. [10].  Epithelial cells were cultured to confluence (~7 days) and treated with fresh medium 193 
24 h in advance of the assay. 10 ml sterile tryptone soy broth (TSB) was inoculated with E. 194 
coli C25 and incubated at 37 °C overnight (15 h), giving a culture entering the stationary 195 
phase of growth (Supplementary Fig 1) and at a density of ~1 x 10
9
 CFU/ml (serial dilutions 196 
and plating out on to tryptone soy agar (TSA) gave exact numbers retrospectively). The 197 
culture was centrifuged at 10,000 x g for 10 min and the bacterial pellet was resuspended in 198 
10 ml HBSS supplemented with 10 mM sodium bicarbonate and 180 mg/dl glucose (Trans-199 
HBSS) in order to reduce bacterial growth during the assay [11]. Epithelial cells were washed 200 
twice in sterile Trans-HBSS, had ~1 x 10
9
 CFU C25 in 2 ml Trans-HBSS added and were 201 
incubated at 37 °C for 4 h. After incubation epithelial cells were washed twice with Trans-202 
HBSS, thus removing any non-adherent/non-internalised bacteria. 1 ml Trans-HBSS/50 203 
µg/ml gentamicin was added to the cells and incubated at room temperature for 15 min, 204 
killing all but the internalised bacteria. The supernatant was removed and plated out neat, in 205 
TSA, to confirm that the antibiotic had killed the extracellular bacteria. The epithelial cells 206 
were lysed by osmotic pressure with the addition of 1 ml sterile deionised water, and 207 
subsequently by sheer force with repeated pipetting, thus releasing the bacteria contained 208 
within the cells. A serial dilution of the resultant lysates was performed to give 10
-3
 and 10
-4
 209 
dilutions, which were subsequently plated out on TSA, using the agar pour plate method. All 210 
resultant plates were incubated overnight at 37°C and bacterial colonies were manually 211 
counted. 212 
 213 
Statistical Analysis 214 
Results are expressed as median ± interquartile range (IQR) for the stated number of 215 
experimental repeats (n). Statistical significance was calculated using Mann Whitney U-test 216 
or Kruskal-Wallis test with Dunn’s post hoc analysis and a p value ≤ 0.05 was considered 217 
significant. All statistical analyses were undertaken using Prism
®
 6 (GraphPad Software Inc.). 218 
  219 
Results 220 
Extracellular products derived from E. coli C25 elicit a moderate proinflammatory 221 
response from IECs 222 
Earlier studies have shown that live E. coli C25 can induce secretion of proinflammatory 223 
cytokines from intestinal epithelial cells [9,14]; however, the extracellular products from this 224 
bacterium have only briefly been considered before [15].  To investigate the inflammatory 225 
potential of E. coli C25-derived extracellular products, HT29-19A and Caco-2 intestinal 226 
epithelial cells lines were challenged with the cell-free supernatant from cultures of E. coli 227 
C25 and sonicated samples of E. coli C25 cultures for 24 h. Sonicated samples were used to 228 
give maximal levels of antigenic material and mimic cells lysed by antimicrobial peptides 229 
(AMPs) in vivo. Additionally, the responses to both cell-free supernatant and sonicates were 230 
compared to the pathogenic antigen, flagellin, which is known to be a major contributing 231 
antigen in the pathology of inflammatory bowel disease [37] and therefore represents a 232 
relevant positive control. Moreover, significant IL-8 release in response to flagellin has 233 
previously been described in both cell lines utilised in this study [38,39]. 234 
E. coli C25 cell-free supernatant was shown to elicit a significant (~5-fold; p ≤ 0.005) 235 
increase in IL-8 release in HT29-19A cells (Fig. 1a). The 1.5-fold increase in IL-8 release in 236 
Caco-2 cells was much more modest (Fig. 1b), but still statistically significant (p ≤ 0.05). The 237 
increased IL-8 release in both cell lines was also reflected at the transcriptional level, with 238 
up-regulation of IL-8 mRNA in both HT29-19A (~9-fold increase; Fig 1c) and Caco-2 (~5-239 
fold increase; Fig. 1d) cells, but neither was statistically significant. Additionally, both HT29-240 
19A and Caco-2 cells exhibited an increased release (~7-fold; p ≤ 0.01 and ~2-fold; p ≤ 0.05, 241 
respectively) of IL-8 when challenged with the sonicated samples of E. coli C25, with levels 242 
comparable to those seen for the cell-free supernatant challenges (Figs. 1a and 1b). 243 
Furthermore, as with cell-free supernatants, challenging with sonicates increased IL-8 mRNA 244 
expression in both cell lines, with HT29-19A cells exhibiting ~20-fold increase (Fig. 1c) and 245 
Caco-2 cells demonstrating a ~4-fold increase (Fig 1 d), although neither of these trends were 246 
calculated to be statistically significant. 247 
Although the release and transcriptional up-regulation of IL-8 was potentiated in 248 
response to the extracellular products of E. coli C25 in both cell lines, when compared to that 249 
observed in response to the pathogenic positive control, 100 ng/ml final concentration 250 
flagellin, the increase is relatively modest (Fig 1); on addition of flagellin, IL-8 release was 251 
~20-fold (p ≤ 0.005) higher in HT29-19A (Fig 1a) and ~40-fold (p ≤ 0.005) in Caco-2 cells 252 
(Fig. 1b), compared to control. mRNA expression was up-regulated ~250-fold (p ≤ 0.01) and 253 
~35-fold (p ≤ 0.01) in HT29-19A (Fig. 1(c)) and Caco-2 cells (Fig. 1d), respectively. Despite 254 
this, upon direct comparison of cells treated with C25 extracellular products and those treated 255 
with flagellin, none of the trends were calculated to be statistically significant. 256 
 257 
Removal of OMVs from E. coli C25 extracellular products reduces their 258 
proinflammatory effect on IECs 259 
Gram negative bacteria are well characterised in their production of outer membrane vesicles 260 
(OMVs) [21,40], which, when derived from either pathogenic or commensal bacteria, have 261 
previously shown immunomodulatory activity on different intestinal cell types [27,29,30]. 262 
Therefore, to elucidate the contribution of OMVs to the proinflammatory profile of E. coli 263 
C25-derived extracellular products, we removed them from the C25 cell-free supernatant via 264 
ultracentrifugation. HT29-19A and Caco-2 cells were subsequently challenged with OMV-265 
free cell-free supernatant (1:10 dilution in cell culture media) for 24 h and the resultant 266 
release of IL-8 was quantified. 267 
 In both cell lines, the release of IL-8 in response to the OMV-free cell-free 268 
supernatant was significantly (p ≤ 0.001) increased from the control (Fig. 1a, 1b and 2). Once 269 
the OMVs had been removed from the supernatant, the level of IL-8 expressed from both cell 270 
lines in response to OMV-free cell-free supernatant appeared to be reduced in comparison to 271 
untampered cell-free supernatant (Fig. 2); nevertheless, it was only statistically significant (p 272 
≤ 0.01) in Caco-2 cells (Fig. 2b) and not HT29-19A (Fig. 2a). Despite appearing to be 273 
increased compared to the control cells, the IL-8 production in cells challenged with the 274 
OMV-free cell-free supernatant was not calculated to be significantly different from these 275 
controls (Fig. 2). 276 
 277 
E. coli C25-derived OMVs elicit a dose-dependent proinflammatory response from 278 
IECs, but have no regulatory effects on TLR mRNA expression. 279 
To investigate the immunomodulatory potential of isolated E. coli C25 outer membrane 280 
vesicles (OMVs), HT29-19A and Caco-2 cells were challenged with a 4-100 µg/ml protein 281 
concentration range of OMVs for 24 h. Release and expression of proinflammatory IL-8 was 282 
investigated by ELISA and qPCR analysis.  283 
In the HT29-19A cell line, an increased level of IL-8 was observed at a 4 µg/ml 284 
concentration of OMVs and increased in a dose-dependent manner; nevertheless, the increase 285 
was only calculated to be statistically significant (p ≤ 0.05) from 20 µg/ml OMVs (Fig. 3a). 286 
Similarly, in Caco-2 cells, 20 µg/ml OMVs was the minimum concentration required to elicit 287 
a statistically significant (p ≤ 0.05) increase in IL-8 secretion (Fig. 3b). A ~6-fold increase in 288 
IL-8 mRNA was produced by 40 µg/ml OMVs in HT29-19A cells (p ≤ 0.001), in contrast, no 289 
change was observed in Caco-2 cells (Fig. 3c). This distinct difference in the responsiveness 290 
to OMVs was again indicative of the phenotypic variance between the two cell lines. OMVs, 291 
which were shown to measure 50-100 nm (Fig 3d), had their protein content compared to that 292 
of the outer membrane (OM) via SDS-PAGE (Fig 3e). The two had very similar protein 293 
compositions, with only subtle differences in band intensity evident; therefore, we can 294 
speculate that the surface protein composition of the OMVs is representative of antigens 295 
present on the whole parent bacterium. 296 
 Previous studies have reported that agonist binding results in the up-regulation of their 297 
cognate TLR receptors [41-43]; we confirmed this phenomenon in the current study by 298 
measuring the regulation of TLR-5 mRNA expression in both cell lines, in response to a 24 h 299 
challenge with 100 ng/ml flagellin. Significant (p ≤ 0.001) up-regulation of TLR-5 mRNA 300 
was observed in HT29-19A cells (~110-fold increase; Supplementary Fig. 2) and Caco-2 301 
cells (~26-fold increase; Supplementary Fig. 2). To investigate whether this was also true in 302 
reaction to commensal-derived antigenic material, we monitored transcriptional expression of 303 
the TLRs most relevant to bacterial antigens (TLRs-1, -2, -4, -5 and -9) in response to E. coli 304 
C25 cell-free supernatant. In HT29-19A cells, we observed a significant (p ≤ 0.05) increase 305 
in all the TLRs tested in response to challenge with cell-free supernatant (Fig 4a). Similarly, 306 
the Caco-2 cell line showed up-regulation in mRNA expression of TLR-1, -4, -5 and -9, 307 
although only the data for TLRs-1 and -9 was considered statistically significant (p ≤ 0.05; 308 
Fig. 4b). Interestingly, cell-free supernatant-challenged Caco-2 cells did not exhibit any 309 
regulation in TLR-2 mRNA expression, as the levels remained comparable to the control. 310 
This was in complete contrast to HT29-19A cells, which showed the largest increase in TLR-311 
2 mRNA expression (~17-fold increase (Fig. 4a)). This contradiction in reaction is likely to 312 
arise from the distinct phenotypic differences between the two cell lines, as Caco-2 cells 313 
exhibit a significant (p ≤ 0.001; ~540-fold) increased constitutive expression in TLR-2 314 
mRNA, when compared to HT29-19A cells (data not shown). 315 
Surprisingly, given the fact that the OMVs possess all the surface antigens of the 316 
parent bacterium (Fig. 3e) when HT29-19A cells were challenged with a 40 µg/ml OMVs no 317 
significant differences were observed in TLR mRNA expression (Fig. 4a), despite TLRs-2, -4 318 
and -5 appearing to be slightly up-regulated and TLR-9 was completely undetectable in the 319 
presence of cell-free supernatant, when compared to the control. Indeed, a number of TLRs 320 
appeared to be down-regulated in Caco-2 cells; however, none of these were statistically 321 
significant (Fig. 4b).  322 
 323 
Pre-incubation with E. coli C25-derived OMVs inhibits the internalisation of the parent 324 
bacterium 325 
As mentioned previously, past studies have utilised E. coli C25 as a model strain for bacterial 326 
translocation across the intestinal epithelium [10,12]; therefore, we sought to investigate the 327 
regulatory ability of OMVs on this process. To explore this, we performed a bacterial 328 
internalisation assay in both HT29-19A and Caco-2 cells. Interestingly, we observed a 329 
reduction in the number of bacteria internalised in both cell lines which had been pre-treated 330 
with 40 µg/ml OMVs (Fig. 5); however, only the decrease seen in Caco-2 cells (~3.5-fold) 331 
was statistically significant (p ≤ 0.05).   332 
Discussion 333 
We have previously described the potential of specific extracellular products derived from 334 
commensal enteric bacteria to modulate the low-level inflammation which exists in intestinal 335 
homeostasis [44,45]; however, there is still a paucity of research in this field. In the present 336 
study, we aimed to explore the inflammatory profile of extracellular products secreted by the 337 
commensal enteric bacterium E. coli C25 on two immortalised intestinal epithelial cell lines, 338 
HT29-19A and Caco-2. Here, we principally demonstrate that the extracellular products of E. 339 
coli C25 (both naturally secreted and after the artificial enhancement of their production via 340 
bacterial sonication) elicit a moderate proinflammatory response, via secretion of the potent 341 
neutrophil chemoattractant, IL-8, from the intestinal cell lines, HT29-19A and Caco-2. In this 342 
study, the cells were cultured on tissue culture plastic, which allowed them to become semi-343 
polarised; however, in future studies it may be more physiologically accurate to culture the 344 
cell lines to complete polarisation on Transwell inserts and examine the effects of E. coli 345 
C25-derived factors on both the apical and basolateral surfaces. 346 
In corroboration with previous studies on these cell lines [46], it is evident that the 347 
two possess a marked difference in constitutive secretion of IL-8 and that their 348 
responsiveness to antigenic material is relatively dissimilar. It has previously been speculated 349 
that HT29 and Caco-2 cell lines were isolated from different cell type populations within the 350 
epithelial layer. HT29 cell lines are thought to originate from hyper-responsive intestinal 351 
epithelial crypt cells [47,48], whereas Caco-2 cells were derived from the more 352 
immunotolerant villus enterocytes [48-50]. Nevertheless, despite the distinct phenotypic 353 
differences between HT29-19A and Caco-2 cells, we were able to confirm a mild 354 
proinflammatory response in both cells lines during challenges with extracellular products 355 
derived from E. coli C25. Also, we show that the naturally secreted products present in cell-356 
free supernatant from cultures of E. coli C25 can induce a modest up-regulation of the major 357 
TLRs associated with recognition of bacterial antigens. As mentioned previously, agonist 358 
binding of TLRs results in the up-regulation of their cognate receptor [41-43] and we 359 
confirmed this phenomenon occurs in IECs in response to flagellin; therefore, from the 360 
mRNA up-regulation of multiple TLRs observed in this study, we can speculate that C25 361 
cell-free supernatant contains multiple TLR ligands. One such secretory product which we 362 
hypothesised to contribute to this was outer membrane vesicles (OMVs). 363 
OMVs isolated from Gram-negative bacteria are receiving increasing interest in 364 
microbiological research [40,51]; yet, despite the vast number of Gram-negative bacteria 365 
present within the intestinal microbiota, there is a lack of studies considering the 366 
immnuoregulatory activity of OMVs derived from this population [32]. Also, the limited 367 
studies performed to date are divided in their opinion of the pontential role of OMVs in the 368 
intestinal niche. It has recently been suggested that macrophage-induced immune responses 369 
to OMVs from the commensal bacterium B. thetaiotaomicron could drive colitis in 370 
genetically susceptible hosts [31]; however, this is contradicted by an elegant study 371 
previously undertaken by Shen et al., which suggests a more beneficial role for commensal-372 
derived OMVs. In their study, they demonstrated that capsular polysaccharide (PSA)-373 
containing OMVs, isolated from B. fragilis, can protect against inflammation in the 2,4,6-374 
trinitrobenzenesulfonic acid (TNBS) experimental model of colitis in mice via the production 375 
of anti-inflammatory cytokines by DCs, which subsequently enhanced the protective 376 
regulatory T cell response [30]. Additionally, Fábrega et al. have recently shown that OMVs 377 
from both probiotic and commensal strains of E. coli stimulate a more anti-inflammatory 378 
cytokine profile from explanted colonic tissue, despite a moderate increase in 379 
proinflammatory cytokines, such as IL-6 and IL-8 [29]. In the current study, we corroborate 380 
the findings of Fábrega et al., as we show that the naturally secreted OMVs of an enteric 381 
commensal bacterium have a direct proinflammatory effect on the intestinal epithelial cell 382 
lines, HT29-19A and Caco-2. However, we suggest that, should this proinflammatory effect 383 
also be observable in vivo, then it is moderate enough to be beneficial to the host by 384 
contributing to the homeostatic low-level inflammatory environment which is characteristic 385 
of the normal intestine. 386 
Previously, it has been shown that OMVs are able to directly interact with host cells 387 
via TLRs [52-55]; nevertheless, we have demonstrated that a relatively high concentration 388 
(40 µg/ml) of C25-derived OMVs does not elicit an up-regulation of TLR mRNA expression, 389 
as was observed in response to the cell-free supernatant from cultures of the parent 390 
bacterium. It is well established that activation of TLRs by their agonists significantly 391 
enhances the internalisation of bacteria in both professional immune cells, such as 392 
macrophages [56,57], and non-professional immune cells, such as intestinal epithelial cells 393 
[58]. In addition to this, E. coli C25 has been used as a model strain for bacterial translocation 394 
through the intestinal epithelial barrier [10,12,13]; therefore, we decided to explore the 395 
regulatory effects of OMVs on this process. Consequently, we demonstrate that pre-treatment 396 
with C25 OMVs was able to reduce the subsequent internalisation of the C25 bacterium in 397 
intestinal epithelial cells.  398 
Therefore, we propose that, through limiting the up-regulation of TLRs by other 399 
secretory products, OMVs can reduce the number of their parent bacterium which translocate 400 
the intestinal epithelial layer. It has been suggested that indigenous bacteria constitutively 401 
translocate transcellularly from the intestinal lumen of healthy, immunocompetent 402 
individuals, but are subsequently killed en route or in situ by professional immune cells once 403 
they reach the lymphoid organs [59]. Furthermore, Lichtman et al. suggested that bacterial 404 
translocation is required to generate immunocompetent cells within the gut-associated 405 
lymphoid tissue (GALT) [60]; however, prolonged and excessive immune reaction to the 406 
microflora leads to the chronic inflammation of the intestinal mucosa classically associated 407 
with inflammatory bowel disease (IBD) [61]. Consequently, in order to maintain the fine 408 
balance of intestinal homeostasis, it is necessary to allow low numbers of commensal bacteria 409 
to translocate the intestinal epithelium; however, it is evident that this process must be 410 
stringently regulated. Here, we propose that, through the production of OMVs, the 411 
commensal microbiota themselves are able to directly contribute to the regulation of their 412 
own translocation, thus maintaining the mutually beneficial symbiosis with a healthy host and 413 
avoiding the pathogenesis of IBD. 414 
In summary, these data demonstrate that, in vitro, extracellular products derived from 415 
a commensal bacterium have a mild proinflammatory effect on host intestinal epithelial cells 416 
and stimulate a moderate up-regulation of TLRs. We hypothesise these effects could be 417 
beneficial in vivo by priming the intestine and subsequently allowing a rapid, but more 418 
controlled, response to pathogenic bacteria and their associated antigens. Also, we show that 419 
OMVs are key contributors to the proinflammatory effect of the E. coli C25-derived 420 
extracellular products. Furthermore, we demonstrate a novel interaction between the 421 
commensal microbiota and host cells; through the inhibition of TLR up-regulation, 422 
membrane vesicles derived from a commensal bacterium are able limit the internalisation of 423 
the parent bacterium into intestinal epithelial cells. Finally, we hypothesise that, were the 424 
results presented here to be representative of the in vivo environment, then the products 425 
secreted into the intestinal milieu by the commensal microbiota, and OMVs in particular, 426 
could play a key role in the induction of the homeostatic low-level inflammatory response 427 
that is highly characteristic of the healthy intestine.  428 
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Table 1 – qPCR primers and probes 620 
 621 
  622 
Gene  Primer Sequence 
Universal 
Probe No. 
GAPDH F – gctctctgctcctcctgttc R – acgaccaaatccgttgactc #60 
IL-8 F – agacagcagagcacacaagc R – aggaaggctgccaagagag #72 
TLR-1 F – aaacaacattgaaacaacttggaa R – cacgtttgaaattgagaaatacca # 65 
TLR-2 F – ctctcggtgtcggaatgtc R – aggatcagcaggaacagagc #56 
TLR-4 F – gaaggttcccagaaaagaatgtt R – cctgattgtccttttcttgaatg # 75 
TLR-5 F – ctccacagtcaccaaaccag R – cctgtgtattgatgggcaaa # 72 
TLR-9 F – tgtgaagcatccttccctgta R – gagagacagcgggtgcag #56 
Figure Legends 623 
Figure 1 – E. coli C25-derived extracellular products elicit IL-8 release expression in 624 
IECs. HT29-19A and Caco-2 cells were challenged with E. coli C25 cell-free supernatant 625 
(1:10 dilution) and sonicated bacteria (1:10 dilution) for 24 h; 100 ng/ml of flagellin was used 626 
a positive pathogenic control. (a) IL-8 release from HT29-19A cells (n = 3-12).  (b) IL-8 627 
release from Caco-2 cells (n = 3-12). (c) mRNA expression of IL-8 in HT29-19A cells (n = 628 
3-6). (d) mRNA expression of IL-8 in HT29-19A cells (n = 3-6). Results are median ± IQR. 629 
*, ** and *** indicate significance from the control, where p ≤ 0.05, 0.01 and 0.005, 630 
respectively. 631 
Figure 2 – Removal of OMVs decreases the proinflammatory activity of E. coli C25-632 
derived extracellular products. E. coli C25 cell-free supernatant was ultracentrifuged to 633 
remove OMVs. The resultant OMV-free cell-free supernatant was diluted 1:10 in cell culture 634 
media and (a) HT29-19A and (b) Caco-2 cells were challenged for 24 h and IL-8 release was 635 
measured via ELISA (n = 6-12). Results are median ± IQR. ** and **** indicate statistical 636 
significance, where p ≤ 0.01 and 0.001, respectively. 637 
Figure 3 – OMVs isolated from E. coli C25 mediate a dose dependent release of IL-8 638 
from IECs. (a) HT29-19A and (b) Caco-2 cells were challenged with serial dilutions (4-100 639 
µg/ml) of E. coli C25 OMVs for 24 h and IL-8 expression was measured (n = 6). (c) mRNA 640 
expression of IL-8 in cells challenged with 40 µg/ml OMVs for 24 h (n = 3). Results are 641 
median ± IQR. *, ** and *** indicate significance from the control, where p ≤ 0.05, 0.01 and 642 
0.005, respectively. (d)TEM micrograph of C25 OMVs. (e) Comparison of protein content of 643 
E. coli C25 outer membrane vesicles (OMV) and outer membrane (OM) preparations by 644 
SDS-PAGE.   645 
Figure 4 – E. coli C25-derived OMVs have no regulatory effects on TLR mRNA 646 
expression. HT29-19A (a) and Caco-2 (b) cells were challenged with 1:10 dilutions of E. coli 647 
C25 cell-free supernatant or 40 µg/ml OMVs culture concentration of E. coli C25 outer 648 
membrane vesicles (C25 OMVs) for 24 h and qPCR was utilised to study TLR mRNA 649 
expression. Results are median ± IQR, n = 3. * and ** indicate significance from the control, 650 
where p ≤ 0.05 and 0.01, respectively. 651 
Figure 5 – Commensal- derived OMVs block internalisation of their parent bacterium. 652 
HT29-19A (a) and Caco-2 (b) cells were challenged with 40 µg/ml E. coli C25 OMVs for 24 653 
h. Subsequently, the supernatants were removed and cell layers were co-cultured with ~1 x 654 
10
9
 CFU of E. coli C25 for 4 h. Non-internalised bacteria were killed and epithelial cells were 655 
lysed, releasing internalised bacteria. Lysates were serially diluted, plated out and incubated 656 
for 24h. Resultant colonies were counted and expressed as a % of the original inoculum. 657 
Results are median ± IQR, n = 4-6. * indicates significance from the control, where p ≤ 0.05.   658 
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Supplementary Figure 1 695 
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 701 
 702 
Supplementary Figure 1 – E. coli C25 growth curve. E. coli C25 was cultured in TSB 703 
broth for 24 h, with the absorbance at 400 nm measured every 30 min. The 15 h culture 704 
time utilised in the experiments in this study is indicated by the dotted line. 705 
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 709 
 710 
 711 
 712 
Supplementary Figure 2 – Flagellin up-regulates TLR5 mRNA expression in IECs. 713 
HT29-19A and Caco-2 cells were challenged with 100 ng/ml final concentration of flagellin 714 
for 24 h and TLR5 mRNA expression was measured. Results are median ± IQR, n = 4-6. * 715 
indicates significance from the control, where p ≤ 0.05. 716 
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